MedTrace Logo

Calprotectin and Ischemia Modified Albumin Serum to Measure Disease Activity in Behçet's Disease

NCT05868538 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2023-05-22

No results posted yet for this study

Summary

Behçet's Disease activity was evaluated using BD Current Activity Form (BDCAF). Serum calprotectin and IMA concentrations were compared among active BD cases, inactive BD cases and control subjects.

Conditions

  • Behçet's Diseasecases

Interventions

DIAGNOSTIC_TEST

Serum calprotectin and IMA concentrations

Serum calprotectin and IMA concentrations were compared among active BD cases, inactive BD cases and control subjects.

Sponsors & Collaborators

  • Mansoura University

    lead OTHER

Principal Investigators

  • Sherin Mashaly, MD · Professor of Rheumatology and Rehabilitation

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-04-01
Primary Completion
2023-03-01
Completion
2023-03-15

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05868538 on ClinicalTrials.gov